Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands

NCT04470921 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT04470921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04470921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2019
Completion date
December 31, 2025
Enrollment
10,000 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer, risk reduction